- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02038582
Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
An Evaluation of Strategies to Increase Testing and Linkages of HIV Positive Individuals to Care and HIV Negative Men to Male Circumcision in Sub-Saharan Africa
Study Overview
Status
Conditions
Detailed Description
New strategies for HIV testing and linkages to care are needed, since only a minority of African adults have been tested in many settings and a drop-off occurs at each step from HIV and CD4 testing, remaining in pre-ART (antiretroviral therapy) care, ART initiation, and adherence over the long term.
This study aims to determine the effects of Point-of-Care (POC) CD4 testing, POC viral load (VL) testing and several linkage strategies (lay-counselor follow-up, accompaniment to HIV clinic by lay counselor, or clinical referral) on linkage to care and treatment adherence for HIV positive persons.
This study also aims to determine the uptake of voluntary circumcision among HIV uninfected males with either promotion at point of HIV testing, Short Message Service (SMS) follow-up or lay counselor follow-up visits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
KwaZulu Natal
-
Sweetwaters, KwaZulu Natal, South Africa
- Human Sciences Research Council (HSRC)
-
-
-
-
Bushenyi
-
Kabwohe, Bushenyi, Uganda
- Intergrated Community Based Initivatives (ICOBI)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Reside in the study community
- Must be 16 years or older
- Able and willing to provide informed consent/assent for study procedures
- HIV negative uncircumcised men must be age 16 - 49 years and have access to secure text messaging to be randomized to strategies for male circumcision.
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: POC CD4 & Clinic Accompaniment
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and follow up with clinic accompaniment
|
Point of Care CD4 testing
Accompaniment to the clinic by a counselor
|
Active Comparator: POC CD4 & Lay Counselor
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and lay counselor follow up
|
Point of Care CD4 testing
Follow-up from a lay counselor
|
Active Comparator: POC CD4 & Clinic Referral
HIV positive persons not on ART at enrollment, randomized to POC CD4 testing and referral to clinic
|
Point of Care CD4 testing
Referral to clinic
|
Active Comparator: CD4 Referral & Clinic Accompaniment
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and follow up with clinic accompaniment
|
Accompaniment to the clinic by a counselor
Referral to CD4 testing
|
Active Comparator: CD4 Referral & Lay Counselor
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and lay counselor follow up
|
Follow-up from a lay counselor
Referral to CD4 testing
|
Active Comparator: CD4 Referral & Clinic Referral
HIV positive persons not on ART at enrollment, randomized to referral for CD4 testing and referral to clinic
|
Referral to clinic
Referral to CD4 testing
|
Active Comparator: Circumcision - SMS Reminder
HIV negative uncircumcised males, randomized to SMS reminder for male circumcision
|
SMS reminder for male circumcision
|
Active Comparator: Circumcision - Lay Counselor
HIV negative uncircumcised males, randomized to lay counselor follow-up for male circumcision
|
Follow-up from a lay counselor
|
Active Comparator: Circumcision - Promotion
HIV negative uncircumcised males, randomized to promotion of male circumcision at the time of HIV testing
|
Promotion of male circumcision at the time of HIV testing
|
Active Comparator: POC VL
HIV positive persons on ART, randomized to POC viral load testing
|
POC VL testing for HIV infected persons on ART
|
Active Comparator: Laboratory based VL assay
HIV positive persons on ART, randomized to laboratory based viral load testing
|
Laboratory based viral load testing for HIV infected persons on ART
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Linkage to care for HIV infected persons not on treatment following a point-of care CD4 count compared to referral to clinic for CD4 testing
Time Frame: Up to 12 Months
|
Proportion of HIV positive individuals in the POC CD4 arm who visit a clinic, obtain a staging CD4 test, initiate ART if eligible, or have a viral load <50 copies/mL within 9 months compared to those in the clinic referral arm.
|
Up to 12 Months
|
Uptake of male circumcision referral among HIV-uninfected men with either promotion at point of HIV testing, SMS follow-up or lay-counselor follow-up visits
Time Frame: Up to 9 months
|
Proportion of HIV-uninfected men who visit a male circumcision clinic or outreach venue for information about circumcision and proportion who report being circumcised by month 3 and 9 in the lay-counselor arm compared to the SMS follow-up arm, and male circumcision promotion at HIV testing arm
|
Up to 9 months
|
Linkage to care for HIV infected persons after lay counselor follow-up, accompaniment to HIV clinic by lay counselor, or clinic referral
Time Frame: Up to 12 months
|
Proportion of HIV positive individuals not on ART at baseline who visit a clinic, obtain a staging CD4 test, initiate ART if eligible, or have a viral load <50 copies/mL within 9 months in the lay counselor follow-up arm compared to the accompaniment and clinic referral arms
|
Up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
POC viral load testing impact on ART adherence and viral suppression compared to standard laboratory testing
Time Frame: Up to 12 months
|
Proportion of HIV positive persons with viral load <50 copies/mL at 3 months among those who receive POC viral load testing compared to those participants who receive standard laboratory-based viral load testing.
|
Up to 12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 44549-A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on POC CD4 Testing
-
Nantes University HospitalMinistry of Health, FranceCompletedBlood Coagulation Disorders | Blood Transfusion | C.Surgical Procedure; Cardiac | Bypass, Cardiopulmonary | HemostaticFrance
-
Wroclaw Medical UniversityUnknownInfluenza | Vaccination | Attitude of Health PersonnelPoland
-
WHO, Department of Maternal, Newborn, Child and...Netherlands: Ministry of Health, Welfare and Sports; Canadian International...Unknown
-
University of WashingtonCompleted
-
Vanderbilt UniversityNational Institutes of Health (NIH)CompletedHIV | Suspected Damage to Fetus From Viral Disease in the MotherNigeria, Niger
-
The Aurum Institute NPCLondon School of Hygiene and Tropical Medicine; Johns Hopkins University; United... and other collaboratorsCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH); Harvard UniversityCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH)Enrolling by invitationPrEP | HIV | PMTCT | Linkage to Care | ART AdherenceUganda
-
Yale UniversityNational Institute on Drug Abuse (NIDA); NYU Langone Health; Kenya National AIDS...Completed
-
University of Alabama at BirminghamUniversity of Colorado, Denver; National Institute of Mental Health (NIMH); University... and other collaboratorsCompletedChronic HIV InfectionKenya